The Travelers Companies TRV Net unrealized gains/(losses) on available-for-sale securities

Net unrealized gains/(losses) on available-for-sale securities at other companies

ESN

Essent GroupESNT

-$7.41M-166%

EVERTECEVTC

-$4K-150%

CBIZCBZ

$22K-51.6%

GeneDx HoldingsWGS

-$253K-437%

Rhythm Pharmaceuticals, Inc.RYTM

-$544K-5,340%

GigaCloud TechnologyGCT

-$8K-33.3%

Other financials

Income statement

See full

Revenue$11.9B+1.0%

Net income$1.7B+333%

EPS (diluted)$7.78+358%

Balance sheet

See full

Cash & equivalents$615.0M-15.1%

Total debt$9.3B+15.4%

Total equity$32.0B+13.5%

Total assets$142.31B+4.7%

Cash flow

See full

Operating cash flow$2.2B+61.6%

Valuation

See full

Market cap$67.68B+12.7%

Enterprise value$76.34B+13.3%

P/E8.9×-5.2×

P/S1.4×+0.1×

Profitability

See full

Net margin15.5%+6.5pp

Returns & leverage

See full

Return on equity25.3%+9.2pp

Debt / equity0.3×0.0×

Where this comes from

Reported directly by The Travelers Companies in its filing.

Tagged under the XBRL concept us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentBeforeTaxPortionAttributableToParent.

The official record: The Travelers Companies’s 10-Q, filed April 16, 2026, on SEC EDGAR. View the filing →

Ask your AI about The Travelers Companies's net unrealized gains/(losses) on available-for-sale securities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is The Travelers Companies's net unrealized gains/(losses) on available-for-sale securities?: The Travelers Companies (TRV) reported net unrealized gains/(losses) on available-for-sale securities of -$1.15B in Q1 2026.
How has The Travelers Companies's net unrealized gains/(losses) on available-for-sale securities changed year-over-year?: The Travelers Companies's net unrealized gains/(losses) on available-for-sale securities decreased by 362.8% year-over-year, from $436M to -$1.15B.